english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years

Rivaroxaban (Xarelto°) for venous thromboembolism in children and adolescents

Prescrire's analysis of EMA's transparency policy over the last 10 years: EMA's reply with Prescrire's comments

In the July-August issue of Prescrire International: Indacaterol + glycopyrronium + mometasone (Enerzair Breezhaler°) in asthma

Covid-19: delays in other types of health care

Delays in access to EMA documents: the Agency confers with Prescrire

Intra-articular corticosteroids: risk of rapid destruction of the hip joint

Abnormal body odour: drugs can be responsible

Prescrire is taking action at the European level

New! "Top Texts of 2022", from the editors of Prescrire International

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90